Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Follow-up of Protective Measles Antibodies in the Two-dose Study of Standard-titre Measles Vaccine in Guinea-Bissau

NCT00168571 is registered in ClinicalTrials.gov with Bandim Health Project as lead sponsor.

NCT NCT00168571
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00168571 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Follow-up of Protective Measles Antibodies in the Two-dose Study of Standard-titre Measles Vaccine in Guinea-Bissau
Lead sponsor
Bandim Health Project
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2002
Completion date
January 31, 2007
Enrollment
1,960
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

measles